title: Abdominal pain: do not forget Thorotrast!
abstract: The use of Thorotrast (25% thorium dioxide), a radiologic contrast agent used up until the mid-1950s, was associated with a wide range of malignancies, mainly of hepatic origin. We report a case of Thorotrast-induced hepatocarcinoma in an 82-year-old woman.
authors.affiliation: Division of Internal Medicine and Endocrinology, University Hospital of Mont-Godinne, Yvoir, Belgium.
authors.forename: E
authors.initials: E
authors.lastname: Weber
authors.forename: F
authors.initials: F
authors.lastname: Laarbaui
authors.forename: L
authors.initials: L
authors.lastname: Michel
authors.forename: J
authors.initials: J
authors.lastname: Donckier
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced*; D013911:Thorium Dioxide / Q000009:adverse effects*
chemical_list: D013911:Thorium Dioxide